- A migraine drugmaker heads to the public markets through reverse merger<figure><div><img src="https://imgproxy.divecdn.com/0Yf4L7bvFRwsrMG85EgRSmundmb9MCnHWX_B23e8BPk/g:nowe:0:0/c:3000:1694/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0…BioPharma Dive · 2mo ago↗ source
- Full-Life Technologies raises $150M; Quince's reboot with pulmonary drugPlus, news about Accro Bioscience, Hansa Biopharma, Shanghai Best-Link Bioscience and UCB. Full-Life Technologies gets $150M: The radiotherapy company has raised $110 million in a Series D round…Endpoints · 2mo ago↗ source
- Relay drug shows early promise against rare blood vessel diseases<figure><div><img src="https://imgproxy.divecdn.com/8hRa8ccyqK4EhEh4oXaIz1XS7XE4MZBhJhutfBJVSSU/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNzUyMzcxMjg5LmpwZ…